{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T02:32:39Z","timestamp":1790389959466,"version":"4.1.0"},"reference-count":21,"publisher":"American Association for the Advancement of Science (AAAS)","issue":"02","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Bio-X Res"],"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:sec>\n            <jats:title>Objective:<\/jats:title>\n            <jats:p>Emetine, an isoquinoline alkaloid that is enriched at high concentrations in the lung, has shown potent in vitro activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The aim of this study was to better understand the effectiveness of low-dose emetine for patients with coronavirus disease 2019 (COVID-19).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>In this real-world study, 63 patients with mild or common COVID-19 were recruited from Wuhan Fangcang Shelter Hospital and five COVID-19-designated hospitals in Anhui Province, China from February to March 2020. Thirty-nine patients from Wuhan Fangcang Shelter Hospital were assigned to a pragmatic randomized controlled clinical trial, and 24 patients from the 5 COVID-19-designated hospitals in Anhui Province underwent a real-world study. The medication course of emetine was less than 10 days. The main symptoms and adverse reactions of all patients were observed and recorded. The primary outcome measure was the time required for a negative SARS-CoV-2 RNA result or the negative result rate on day 10. Secondary outcomes included axillary temperature, transcutaneous oxygen saturation, and respiratory frequency recovery. The study was approved by the Ethics Committee of The First Affiliated Hospital of Anhui Medical University on February 20, 2019 (approval No. PJ2020-03-19) and was registered with the Chinese Clinical Trial Registry on February 20, 2019 (registration number: ChiCTR2000030022).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The oxygen saturation values were higher in the treatment group than in the control group on the first day after enrollment for patients treated at Fangcang Shelter Hospital. The axillary body temperature, respiratory rate, and oxygen saturation among patients in Fangcang Shelter Hospital were related to the time effect but not to the intervention measures. The respiratory rate and oxygen saturation of patients in the Anhui designated hospitals were related to the intervention measures but not to the time effect. The axillary body temperature of patients in Anhui designated hospitals was related to the time effect but not to the intervention measures.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Our preliminary study shows that low-dose emetine combined with basic conventional antiviral drugs improves clinical symptoms in patients with mild and common COVID-19 without apparent adverse effects, suggesting that moderately increased doses of emetine may have good potential for treatment and prevention of COVID-19.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/jbr.0000000000000076","type":"journal-article","created":{"date-parts":[[2020,12,5]],"date-time":"2020-12-05T04:00:27Z","timestamp":1607140827000},"page":"53-59","source":"Crossref","is-referenced-by-count":13,"title":["Clinical efficacy of low-dose emetine for patients with COVID-19: a real-world study"],"prefix":"10.34133","volume":"04","author":[{"given":"Song","family":"Fan","sequence":"first","affiliation":[{"name":"Department of Urology, the First Affiliated Hospital of Anhui Medical University, Institute of Urology, Anhui Medical University and Anhui Province Key Laboratory of Genitourinary Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhen","sequence":"additional","affiliation":[{"name":"Department of Dermatology, the First Affiliated Hospital of Anhui Medical University, Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, Inflammation and Immune Mediated Diseases Laboratory of Anhui Province"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Chen","sequence":"additional","affiliation":[{"name":"High Magnetic Field Laboratory, Key Laboratory of High Magnetic Field and Ion Beam Physical Biology, Hefei Institutes of Physical Science, Chinese Academy of Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, the First Affiliated Hospital of Anhui Medical University, Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, Inflammation and Immune Mediated Diseases Laboratory of Anhui Province"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qibing","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, the First Affiliated Hospital of Anhui Medical University, Hefei"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huihui","family":"Ma","sequence":"additional","affiliation":[{"name":"Anhui Lixin County Hospital of Traditional Chinese Medicine, Bozhou"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengyuan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Anhui Feidong County People\u2019s Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[{"name":"Center for Scientific Research of the First Affiliated Hospital of Anhui Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baojing","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Microbiology, School of Basic Medical Science, Anhui Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiyao","family":"Ge","sequence":"additional","affiliation":[{"name":"Department of Dermatology, the First Affiliated Hospital of Anhui Medical University, Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, Inflammation and Immune Mediated Diseases Laboratory of Anhui Province"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Yong","sequence":"additional","affiliation":[{"name":"Department of Dermatology, the First Affiliated Hospital of Anhui Medical University, Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, Inflammation and Immune Mediated Diseases Laboratory of Anhui Province"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao","family":"Li","sequence":"additional","affiliation":[{"name":"Comprehensive Lab, College of Basic, Anhui Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yafen","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, the First Affiliated Hospital of Anhui Medical University, Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, Inflammation and Immune Mediated Diseases Laboratory of Anhui Province"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Dermatology, the First Affiliated Hospital of Anhui Medical University, Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, Inflammation and Immune Mediated Diseases Laboratory of Anhui Province"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwen","family":"Mao","sequence":"additional","affiliation":[{"name":"Department of Dermatology, the First Affiliated Hospital of Anhui Medical University, Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, Inflammation and Immune Mediated Diseases Laboratory of Anhui Province"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangbo","family":"Qu","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Health Statistics, School of Public Health, Anhui Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Su","sequence":"additional","affiliation":[{"name":"Traditional and Western Medicine (TCM)-Integrated Cancer Center of Anhui Medical University, the Department of Traditional and Western Integrative Medicine Oncology, the First Affiliated Hospital of Anhui Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aoli","family":"Wang","sequence":"additional","affiliation":[{"name":"High Magnetic Field Laboratory, Key Laboratory of High Magnetic Field and Ion Beam Physical Biology, Hefei Institutes of Physical Science, Chinese Academy of Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Binhu Hospital of Hefei"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiwen","family":"Li","sequence":"additional","affiliation":[{"name":"The Third Affiliated Hospital of Anhui Medical University, the First Affiliated Hospital of Zhengzhou University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Zhang","sequence":"additional","affiliation":[{"name":"The Second People\u2019s Hospital of Hefei"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonglian","family":"Wang","sequence":"additional","affiliation":[{"name":"The Second People\u2019s Hospital of Hefei"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufeng","family":"Gao","sequence":"additional","affiliation":[{"name":"The Department of Infectious Diseases, the First Affiliated Hospital of Anhui Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xihai","family":"Xu","sequence":"additional","affiliation":[{"name":"The Department of Infectious Diseases, the First Affiliated Hospital of Anhui Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongming","family":"Zhu","sequence":"additional","affiliation":[{"name":"The Department Pulmonary and Critical Care Medicine, the First Affiliated Hospital of Anhui Medical University, Hefei, Anhui Province"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Chen","sequence":"additional","affiliation":[{"name":"Anhui Suzhou Hospital, Suzhou, Jiangsu Province"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Zhang","sequence":"additional","affiliation":[{"name":"Anhui Suzhou Hospital, Suzhou, Jiangsu Province"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongqiang","family":"Liang","sequence":"additional","affiliation":[{"name":"Anhui Feidong County People\u2019s Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Wu","sequence":"additional","affiliation":[{"name":"Anhui Feidong County People\u2019s Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Huang","sequence":"additional","affiliation":[{"name":"Anhui Feidong County People\u2019s Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Xia","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, the First Affiliated Hospital of Anhui Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Li","sequence":"additional","affiliation":[{"name":"Traditional and Western Medicine (TCM)-Integrated Cancer Center of Anhui Medical University, the Department of Traditional and Western Integrative Medicine Oncology, the First Affiliated Hospital of Anhui Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehuan","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Health Statistics, School of Public Health, Anhui Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaozhao","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Urology, the First Affiliated Hospital of Anhui Medical University, Institute of Urology, Anhui Medical University and Anhui Province Key Laboratory of Genitourinary Diseases"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[{"name":"Institute of Clinical Pharmacology, Anhui Medical University, Key Laboratory of Anti-Inflammatory and Immune Medicine, Ministry of Education, Anhui Collaborative Innovation Center of Anti-Inflammatory and Immune Medicine, Hefei, Anhui Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingsong","family":"Liu","sequence":"additional","affiliation":[{"name":"High Magnetic Field Laboratory, Key Laboratory of High Magnetic Field and Ion Beam Physical Biology, Hefei Institutes of Physical Science, Chinese Academy of Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangdan","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Dermatology, the First Affiliated Hospital of Anhui Medical University, Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, Inflammation and Immune Mediated Diseases Laboratory of Anhui Province"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","published-online":{"date-parts":[[2021,6,25]]},"reference":[{"key":"e_1_3_7_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30211-7"},{"key":"e_1_3_7_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30251-8"},{"key":"e_1_3_7_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30076-X"},{"key":"e_1_3_7_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30183-5"},{"key":"e_1_3_7_6_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1091"},{"key":"e_1_3_7_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30154-9"},{"key":"e_1_3_7_8_2","first-page":"1824","article-title":"Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review","volume":"323","author":"Sanders JM","year":"2020","unstructured":"Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB. Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review. JAMA 2020;323:1824-1836.","journal-title":"JAMA"},{"key":"e_1_3_7_9_2","doi-asserted-by":"crossref","first-page":"e1005717","DOI":"10.1371\/journal.ppat.1005717","article-title":"Efficacy and mechanism of action of low dose emetine against human cytomegalovirus","volume":"12","author":"Mukhopadhyay R","year":"2016","unstructured":"Mukhopadhyay R, Roy S, Venkatadri R, et al. Efficacy and mechanism of action of low dose emetine against human cytomegalovirus. PLoS Pathog 2016;12:e1005717.","journal-title":"PLoS Pathog"},{"key":"e_1_3_7_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2332-7"},{"key":"e_1_3_7_11_2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3390\/ph13030051","article-title":"Emetine, Ipecac, Ipecac Alkaloids and Analogues as Potential Antiviral Agents for Coronaviruses","volume":"13","author":"Bleasel MD","year":"2020","unstructured":"Bleasel MD, Peterson GM. Emetine, Ipecac, Ipecac Alkaloids and Analogues as Potential Antiviral Agents for Coronaviruses. Pharmaceuticals (Basel) 2020;13:51.","journal-title":"Pharmaceuticals (Basel)"},{"key":"e_1_3_7_12_2","doi-asserted-by":"crossref","first-page":"105949","DOI":"10.1016\/j.ijantimicag.2020.105949","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an openlabel non-randomized clinical trial","volume":"56","author":"Gautret P","year":"2020","unstructured":"Gautret P, Lagier JC, Parola P, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an openlabel non-randomized clinical trial. Int J Antimicrob Agents 2020;56:105949.","journal-title":"Int J Antimicrob Agents"},{"key":"e_1_3_7_13_2","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1001\/jama.2020.4742","article-title":"Treating COVID-19-Off-Label drug use, compassionate use, and randomized clinical trials during pandemics","volume":"323","author":"Kalil AC","year":"2020","unstructured":"Kalil AC. Treating COVID-19-Off-Label drug use, compassionate use, and randomized clinical trials during pandemics. JAMA 2020;323:1897-1898.","journal-title":"JAMA"},{"key":"e_1_3_7_14_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2020.0994"},{"key":"e_1_3_7_15_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.1585"},{"key":"e_1_3_7_16_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001282"},{"key":"e_1_3_7_17_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001191"},{"key":"e_1_3_7_18_2","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.jinf.2020.03.060","article-title":"Arbidol monotherapy is superior to lopinavir\/ritonavir in treating COVID-19","volume":"81","author":"Zhu Z","year":"2020","unstructured":"Zhu Z, Lu Z, Xu T, et al. Arbidol monotherapy is superior to lopinavir\/ritonavir in treating COVID-19. J Infect 2020;81:e21-e23.","journal-title":"J Infect"},{"key":"e_1_3_7_19_2","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/cid\/ciaa272","article-title":"Clinical features of 69 cases with coronavirus disease 2019 in Wuhan, China","volume":"71","author":"Wang Z","year":"2020","unstructured":"Wang Z, Yang B, Li Q, et al. Clinical features of 69 cases with coronavirus disease 2019 in Wuhan, China. Clin Infect Dis 2020;71:769-777.","journal-title":"Clin Infect Dis"},{"key":"e_1_3_7_20_2","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jinf.2020.03.002","article-title":"Arbidol combined with LPV\/r versus LPV\/r alone against corona virus disease 2019: a retrospective cohort study","volume":"81","author":"Deng L","year":"2020","unstructured":"Deng L, Li C, Zeng Q, et al. Arbidol combined with LPV\/r versus LPV\/r alone against corona virus disease 2019: a retrospective cohort study. J Infect 2020;81:e1-5.","journal-title":"J Infect"},{"key":"e_1_3_7_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2017.06.006"},{"key":"e_1_3_7_22_2","doi-asserted-by":"crossref","first-page":"11474","DOI":"10.3390\/molecules200611474","article-title":"Natural Plant Alkaloid (Emetine) inhibits HIV-1 replication by interfering with reverse transcriptase activity","volume":"20","author":"Chaves VA","year":"2015","unstructured":"Chaves VA, Abreu CM, Dias JZ, et al. Natural Plant Alkaloid (Emetine) inhibits HIV-1 replication by interfering with reverse transcriptase activity. Molecules 2015;20:11474-11489.","journal-title":"Molecules"}],"container-title":["Journal of Bio-X Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spj.science.org\/doi\/pdf\/10.1097\/JBR.0000000000000076","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T20:03:37Z","timestamp":1718395417000},"score":1,"resource":{"primary":{"URL":"https:\/\/spj.science.org\/doi\/10.1097\/JBR.0000000000000076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":21,"journal-issue":{"issue":"02","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["10.1097\/JBR.0000000000000076"],"URL":"https:\/\/doi.org\/10.1097\/jbr.0000000000000076","relation":{},"ISSN":["2096-5672","2577-3585"],"issn-type":[{"value":"2096-5672","type":"print"},{"value":"2577-3585","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6]]}}}